DNMT3A and Stroke: In the present study, we found that stroke patients were characterized by TLN2 hypermethylation, while in vitro modulation of DNA methylation at the TLN2 locus via CRISPR/dCas9-Dnmt3a system revealed a positive association between TLN2 methylation and TLN2 expression.